What was the market valuation of the US scoliosis treatment market in 2024?

The market valuation of the US scoliosis treatment market was $36.1 Billion in 2024. Read More

What is the projected market valuation for the US scoliosis treatment market by 2035?

The projected market valuation for the US scoliosis treatment market is $123.82 Billion by 2035. Read More

What is the expected CAGR for the US scoliosis treatment market during the forecast period 2025 - 2035?

The expected CAGR for the US scoliosis treatment market during the forecast period 2025 - 2035 is 11.86%. Read More

Which segments contributed to the US scoliosis treatment market valuation in 2024?

In 2024, segments such as Adolescent Idiopathic Scoliosis and Thoracolumbosacral Orthosis (TLSO) contributed significantly to the market valuation. Read More

What are the key players in the US scoliosis treatment market?

Key players in the US scoliosis treatment market include Medtronic, Stryker, NuVasive, Zimmer Biomet, DePuy Synthes, Orthofix, Globus Medical, and K2M. Read More

What was the valuation of the Adolescent Idiopathic Scoliosis segment in 2024?

The valuation of the Adolescent Idiopathic Scoliosis segment was $31.1 Billion in 2024. Read More

How much is the Thoracolumbosacral Orthosis (TLSO) segment expected to grow by 2035?

The Thoracolumbosacral Orthosis (TLSO) segment is expected to grow to $42.0 Billion by 2035. Read More

What distribution channels are involved in the US scoliosis treatment market?

Distribution channels in the US scoliosis treatment market include Hospitals & Clinics, Retail Pharmacies, and Online Pharmacies. Read More

What was the market valuation for Hospitals & Clinics in 2024?

The market valuation for Hospitals & Clinics was $20.0 Billion in 2024. Read More

What is the projected valuation for the Lumbosacral Orthosis (LSO) segment by 2035?

The projected valuation for the Lumbosacral Orthosis (LSO) segment is $51.82 Billion by 2035. Read More

US Scoliosis Treatment Market

ID: MRFR/HC/50452-HCR 128 Pages Nidhi Mandole Last Updated: September 17, 2026

US Scoliosis Treatment Market Research Report: Size, Share, Trend Analysis By Disease (Infantile Idiopathic Scoliosis, Adolescent Idiopathic Scoliosis), By Product (Cervical Thoracic Lumbar Sacral Orthosis (CTLSO), Thoracolumbosacral Orthosis (TLSO), Lumbosacral Orthosis (LSO) and By Distribution Channel (Hospitals & Clinics, Retail Pharmacies, Online Pharmacies) - Growth Outlook & Industry Forecast 2025 To 2035

US Scoliosis Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)11.86%

2024 Market Size$ 36.1 Billion

2025 Market Size$ 40.38 Billion

2035 Market Size$ 123.82 Billion

Key Players

Medtronic

Stryker

NuVasive

Zimmer Biomet

DePuy Synthes

Orthofix

Trends

Technological Advancements in Treatment
Increased Focus on Early Detection
Integration of Telemedicine

Opportunities

Expansion of Healthcare Access
Rising Prevalence of Scoliosis
Increased Awareness and Education

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Food, Beverages & Nutrition, BY Disease (USD Billion)
  1. 4.1.1 Infantile Idiopathic Scoliosis
  2. 4.1.2 Adolescent Idiopathic Scoliosis
2. 4.2 Food, Beverages & Nutrition, BY Product (USD Billion)
  1. 4.2.1 Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
  2. 4.2.2 Thoracolumbosacral Orthosis (TLSO)
  3. 4.2.3 Lumbosacral Orthosis (LSO)
3. 4.3 Food, Beverages & Nutrition, BY Distribution Channel (USD Billion)
  1. 4.3.1 Hospitals & Clinics
  2. 4.3.2 Retail Pharmacies
  3. 4.3.3 Online Pharmacies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Stryker (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 NuVasive (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Zimmer Biomet (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 DePuy Synthes (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Orthofix (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Globus Medical (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 K2M (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY DISEASE
3. 6.3 US MARKET ANALYSIS BY PRODUCT
4. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
5. 6.5 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
8. 6.8 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
9. 6.9 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
10. 6.10 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
11. 6.11 FOOD, BEVERAGES & NUTRITION, BY DISEASE, 2024 (% SHARE)
12. 6.12 FOOD, BEVERAGES & NUTRITION, BY DISEASE, 2024 TO 2035 (USD Billion)
13. 6.13 FOOD, BEVERAGES & NUTRITION, BY PRODUCT, 2024 (% SHARE)
14. 6.14 FOOD, BEVERAGES & NUTRITION, BY PRODUCT, 2024 TO 2035 (USD Billion)
15. 6.15 FOOD, BEVERAGES & NUTRITION, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
16. 6.16 FOOD, BEVERAGES & NUTRITION, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY DISEASE, 2025-2035 (USD Billion)
  2. 7.2.2 BY PRODUCT, 2025-2035 (USD Billion)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Scoliosis Treatment Market Segmentation

US Scoliosis Treatment Market By Disease (USD Billion, 2025-2035)

Infantile Idiopathic Scoliosis
Adolescent Idiopathic Scoliosis

US Scoliosis Treatment Market By Product (USD Billion, 2025-2035)

Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)
Thoracolumbosacral Orthosis (TLSO)
Lumbosacral Orthosis (LSO)

US Scoliosis Treatment Market By Distribution Channel (USD Billion, 2025-2035)

Hospitals & Clinics
Retail Pharmacies
Online Pharmacies

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”